• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Ishiguro Kazuya  石黒 一也

ORCIDConnect your ORCID iD *help
… Alternative Names

石黒 一也  イシグロ カズヤ

Less
Researcher Number 90784439
Other IDs
Affiliation (Current) 2026: 札幌医科大学, 医学部, 助教
Affiliation (based on the past Project Information) *help 2022 – 2025: 札幌医科大学, 医学部, 助教
2019 – 2021: 札幌医科大学, 医学部, 訪問研究員
2016 – 2017: 札幌医科大学, 医学部, 研究員
Review Section/Research Field
Principal Investigator
Basic Section 54010:Hematology and medical oncology-related
Except Principal Investigator
Basic Section 53010:Gastroenterology-related / Medium-sized Section 57:Oral science and related fields / Hematology
Keywords
Principal Investigator
多発性骨髄腫 / エピジェネティクス / ヒストンメチル化 / DOT1L
Except Principal Investigator
腫瘍微小環境 / がん線維芽細胞 / 細胞外マトリックス / 腫瘍免疫 / ACLP / 大腸がん … More / AEBP1 / 筋芽細胞 / ゲノム / エピジェネッティック / メチル化 / ヒストンメチル化 / エピジェネティクス / 多発性骨髄腫 Less
  • Research Projects

    (5 results)
  • Research Products

    (28 results)
  • Co-Researchers

    (9 People)
  •  Development of innovative therapy targeting tumor microenvironment of oral squamous cell carcinoma

    • Principal Investigator
      鈴木 拓
    • Project Period (FY)
      2025 – 2027
    • Research Category
      Grant-in-Aid for Challenging Research (Exploratory)
    • Review Section
      Medium-sized Section 57:Oral science and related fields
    • Research Institution
      Sapporo Medical University
  •  自然免疫応答に着目した多発性骨髄腫の新規エピジェネティック治療の開発Principal Investigator

    • Principal Investigator
      石黒 一也
    • Project Period (FY)
      2024 – 2025
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 54010:Hematology and medical oncology-related
    • Research Institution
      Sapporo Medical University
  •  大腸癌微小環境における癌線維芽細胞の活性化とCD8陽性T細胞浸潤抑制の病態解明

    • Principal Investigator
      山本 英一郎
    • Project Period (FY)
      2024 – 2026
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 53010:Gastroenterology-related
    • Research Institution
      Sapporo Medical University
  •  Development of a new myeloma therapy targeting DOT1LPrincipal Investigator

    • Principal Investigator
      Ishiguro Kazuya
    • Project Period (FY)
      2021 – 2022
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 54010:Hematology and medical oncology-related
    • Research Institution
      Sapporo Medical University
  •  Genome methylation approach to search mechanisms of malignancy and new therapeutic targets in multiple myeloma

    • Principal Investigator
      ISHIDA Tadao
    • Project Period (FY)
      2015 – 2017
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Hematology
    • Research Institution
      Sapporo Medical University

All 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015

All Journal Article Presentation

  • [Journal Article] Downregulation of SMOC1 is associated with progression of colorectal traditional serrated adenomas2024

    • Author(s)
      Aoki Hironori、Takasawa Akira、Yamamoto Eiichiro、Niinuma Takeshi、Yamano Hiro-o、Harada Taku、Kubo Toshiyuki、Yorozu Akira、Kitajima Hiroshi、Ishiguro Kazuya、Kai Masahiro、Katanuma Akio、Shinohara Toshiya、Nakase Hiroshi、Sugai Tamotsu、Osanai Makoto、Suzuki Hiromu
    • Journal Title

      BMC Gastroenterology

      Volume: 24 Issue: 1 Pages: 91-91

    • DOI

      10.1186/s12876-024-03175-1

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-23K07420, KAKENHI-PROJECT-21K07985, KAKENHI-PROJECT-22K07964, KAKENHI-PROJECT-23K24186, KAKENHI-PROJECT-23K06445, KAKENHI-PROJECT-24K11157
  • [Journal Article] AEBP1 is a negative regulator of skeletal muscle cell differentiation in oral squamous cell carcinoma2024

    • Author(s)
      Okazaki Fumika、Yorozu Akira、Sekiguchi Shohei、Niinuma Takeshi、Maruyama Reo、Kitajima Hiroshi、Yamamoto Eiichiro、Ishiguro Kazuya、Toyota Mutsumi、Hatanaka Yui、Nishiyama Koyo、Ogi Kazuhiro、Kai Masahiro、Takano Kenichi、Ichimiya Shingo、Miyazaki Akihiro、Suzuki Hiromu
    • Journal Title

      Scientific Reports

      Volume: 14 Issue: 1 Pages: 27425-27425

    • DOI

      10.1038/s41598-024-79061-3

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-21K07985, KAKENHI-PROJECT-22K17188, KAKENHI-PROJECT-23K24186, KAKENHI-PROJECT-23K27386, KAKENHI-PROJECT-24K11157, KAKENHI-PROJECT-24K12676, KAKENHI-PROJECT-24K20001
  • [Journal Article] LINC02154 promotes cell cycle and mitochondrial function in oral squamous cell carcinoma2024

    • Author(s)
      Niinuma Takeshi、Kitajima Hiroshi、Sato Tatsuya、Ogawa Toshifumi、Ishiguro Kazuya、Kai Masahiro、Yamamoto Eiichiro、Hatanaka Yui、Nojima Iyori、Toyota Mutsumi、Yorozu Akira、Sekiguchi Shohei、Tohse Noritsugu、Furuhashi Masato、Ohguro Hiroshi、Miyazaki Akihiro、Suzuki Hiromu
    • Journal Title

      Cancer Science

      Volume: 116 Issue: 2 Pages: 393-405

    • DOI

      10.1111/cas.16379

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-21K07985, KAKENHI-PROJECT-22K17188, KAKENHI-PROJECT-23K24186, KAKENHI-PROJECT-24K11157, KAKENHI-PROJECT-24K20001
  • [Journal Article] HOXA11-As Promotes Lymph Node Metastasis Through Regulation of IFNL and HMGB Family Genes in Pancreatic Cancer2024

    • Author(s)
      Nishiyama Hayato、Niinuma Takeshi、Kitajima Hiroshi、Ishiguro Kazuya、Yamamoto Eiichiro、Sudo Gota、Sasaki Hajime、Yorozu Akira、Aoki Hironori、Toyota Mutsumi、Kai Masahiro、Suzuki Hiromu
    • Journal Title

      International Journal of Molecular Sciences

      Volume: 25 Issue: 23 Pages: 12920-12920

    • DOI

      10.3390/ijms252312920

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-21K07945, KAKENHI-PROJECT-21K07985, KAKENHI-PROJECT-22K07964, KAKENHI-PROJECT-21K15556, KAKENHI-PROJECT-22K16001, KAKENHI-PROJECT-23K24186, KAKENHI-PROJECT-24K11157
  • [Journal Article] Dual EZH2 and G9a inhibition suppresses multiple myeloma cell proliferation by regulating the interferon signal and IRF4-MYC axis.2021

    • Author(s)
      Ishiguro K, Kitajima H, Niinuma T, Maruyama R, Nishiyama N, Ohtani H, Sudo G, Toyota M, Sasaki H, Yamamoto E, Kai M, Nakase H, Suzuki H.
    • Journal Title

      Cell Death Discovery

      Volume: 7 Issue: 1 Pages: 7-7

    • DOI

      10.1038/s41420-020-00400-0

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K17836, KAKENHI-PROJECT-18K07949, KAKENHI-PROJECT-18K15220, KAKENHI-PROJECT-19K17468, KAKENHI-PROJECT-20K17057, KAKENHI-PROJECT-19H03518, KAKENHI-PROJECT-21K15556
  • [Journal Article] Molecular diagnostics of a single drug-resistant multiple myeloma case using targeted next-generation sequencing.2015

    • Author(s)
      Ikeda H, Ishiguro K, Igarashi T, Aoki Y, Hayashi T, Ishida T, Sasaki Y, Tokino T, Shinomura Y.
    • Journal Title

      Onco Targets Ther.

      Volume: 8 Pages: 2805-2815

    • DOI

      10.2147/ott.s86515

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-15K09456, KAKENHI-PROJECT-26460944
  • [Journal Article] Decrease of B-type natriuretic peptide to less than 200 pg/mL predicts longer survival in cardiac immunoglobulin light chain amyloidosis.2015

    • Author(s)
      Ishiguro K, Hayashi T, Igarashi T, Maruyama Y, Ikeda H, Ishida T, Shinomura Y.
    • Journal Title

      Int J Hematol.

      Volume: 102 Issue: 2 Pages: 200-204

    • DOI

      10.1007/s12185-015-1814-0

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-15K09456
  • [Presentation] 胃がん関連長鎖non-coding RNA TM4SF1-AS1はストレス顆粒形成を介してアポトーシスの阻害に関与する.2024

    • Author(s)
      北嶋洋志,丸山玲緒,新沼猛,髙澤啓,山本英一郎,石黒一也,甲斐正広,小山内誠,時野隆至,仲瀬裕志,鈴木拓.
    • Organizer
      第35回日本消化器癌発生学会総会
    • Data Source
      KAKENHI-PROJECT-24K11157
  • [Presentation] 多発性骨髄腫においてDOT1L阻害は自然免疫シグナルを活性化する2023

    • Author(s)
      石黒一也、北嶋洋志、新沼猛、丸山玲緒、塚原 智英、廣橋 良彦、粂川昂平、関口翔平、佐々木基、吉戸文乃、甲斐正広、鳥越俊彦、仲瀬裕志、鈴木拓
    • Organizer
      第127回北海道癌談話会例会
    • Data Source
      KAKENHI-PROJECT-23K15329
  • [Presentation] 多発性骨髄腫においてDOT1L阻害は自然免疫シグナルを活性化する2023

    • Author(s)
      石黒一也、北嶋洋志、新沼猛、丸山玲緒、塚原智英、粂川昴平、関口翔平、佐々木基、甲斐正広、仲瀬裕志、鈴木拓
    • Organizer
      第16回日本エピジェネティクス研究会年会
    • Data Source
      KAKENHI-PROJECT-23K15329
  • [Presentation] DOT1L inhibition activates innate immune signaling in multiple myeloma2023

    • Author(s)
      Kazuya Ishiguro, Hiroshi Kitajima, Takeshi Niinuma, Reo Maruyama, Tomohide Tsukahara, Yoshihiko Hirohashi, Kohei Kumegawa, Shohei Sekiguchi, Hajime Sasaki, Masahiro Kai, Toshihiko Torigoe, Hiroshi Nakase and Hiromu Suzuki
    • Organizer
      2nd JCA-AACR Precision Cancer Medicine International Conference
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-23K15329
  • [Presentation] DOT1L inhibition activates innate immune signaling in multiple myeloma2023

    • Author(s)
      Kazuya Ishiguro, Hiroshi Kitajima, Takeshi Niinuma, Reo Maruyama, Tomohide Tsukahara, Yoshihiko Hirohashi, Kohei Kumegawa, Shohei Sekiguchi, Hajime Sasaki, Masahiro Kai, Toshihiko Torigoe, Hiroshi Nakase and Hiromu Suzuki
    • Organizer
      第82回日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-23K15329
  • [Presentation] 多発性骨髄腫においてDOT1L阻害は自然免疫シグナルを活性化し、免疫調節薬の効果を増強する2023

    • Author(s)
      石黒一也、北嶋洋志、新沼猛、丸山玲緒、塚原 智英、廣橋 良彦、粂川昂平、関口翔平、佐々木基、甲斐正広、五十嵐哲祥、鳥越 俊彦、仲瀬裕志、鈴木拓
    • Organizer
      第85回日本血液学会学術総会
    • Data Source
      KAKENHI-PROJECT-23K15329
  • [Presentation] 多発性骨髄腫においてDOT1L阻害は免疫シグナルを活性化する2022

    • Author(s)
      石黒 一也
    • Organizer
      第125回北海道癌談話会例会
    • Data Source
      KAKENHI-PROJECT-19K17836
  • [Presentation] DOT1L inhibition activates immunologic signatures in multiple myeloma2022

    • Author(s)
      石黒 一也
    • Organizer
      第81回日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-19K17836
  • [Presentation] Dual inhibition of EZH2 and G9a suppresses multiple myeloma cell proliferation by affecting interferon signaling2021

    • Author(s)
      石黒一也
    • Organizer
      第46回日本骨髄腫学会学術総会
    • Data Source
      KAKENHI-PROJECT-19K17836
  • [Presentation] The anti-myeloma effect of dual EZH2 and G9a inhibition2021

    • Author(s)
      石黒一也
    • Organizer
      第83回日本血液学会学術総会
    • Data Source
      KAKENHI-PROJECT-19K17836
  • [Presentation] Dual inhibition of EZH2 and G9a suppresses multiple myeloma cell proliferation by affecting interferon signaling2021

    • Author(s)
      石黒一也
    • Organizer
      第14回日本エピジェネティクス研究会年会
    • Data Source
      KAKENHI-PROJECT-19K17836
  • [Presentation] Development of a new epigenetic immunotherapy for multiple myeloma2021

    • Author(s)
      石黒一也
    • Organizer
      第80回日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-19K17836
  • [Presentation] Development of a new combinational epigenetic treatment for multiple myeloma2020

    • Author(s)
      石黒一也
    • Organizer
      第79回日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-19K17836
  • [Presentation] EZH2とG9aの共阻害はインターフェロンシグナルの活性化とIRF-4-MYC axisの抑制により多発性骨髄腫細胞の増殖を抑制する2020

    • Author(s)
      石黒一也
    • Organizer
      第121回北海道癌談話会例会
    • Data Source
      KAKENHI-PROJECT-19K17836
  • [Presentation] Development of a new combinational epigenetic therapy of multiple myeloma2019

    • Author(s)
      Kazuya Ishiguro
    • Organizer
      第38回札幌国際がんシンポジウム
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19K17836
  • [Presentation] 多発性骨髄腫に対するDOT1L阻害の抗腫瘍効果の検討2019

    • Author(s)
      石黒一也
    • Organizer
      第5回がんゲノム・エピゲノム研究会
    • Data Source
      KAKENHI-PROJECT-19K17836
  • [Presentation] 多発性骨髄腫における新規エピジェネティック併用療法の開発2019

    • Author(s)
      石黒一也
    • Organizer
      第78回日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-19K17836
  • [Presentation] 多発性骨髄腫に対するDOT1L阻害の抗腫瘍効果の解析2019

    • Author(s)
      石黒一也
    • Organizer
      第120回北海道癌談話会例会
    • Data Source
      KAKENHI-PROJECT-19K17836
  • [Presentation] The histone methyltransferase DOT1L is a potential therapeutic target in multiple myeloma2018

    • Author(s)
      Kazuya Ishiguro, Hiroshi Kitajima, Takeshi Niinuma, Tadao Ishida, Reo Maruyama, Hiroshi Ikeda, Toshiaki Hayashi, Hajime Sasaki, Hideki Wakasugi, Koyo Nishiyama, Tetsuya Shindo, Eiichiro Yamamoto, Masahiro Kai, Yasushi Sasaki, Takashi Tokino, Hiroshi Nakase and Hiromu Suzuki
    • Organizer
      Targeting DNA Methylation and Chromatin for Cancer Therapy
    • Data Source
      KAKENHI-PROJECT-15K09456
  • [Presentation] ヒストンメチル化酵素DOT1Lは多発性骨髄腫の治療標的となりうる2017

    • Author(s)
      石黒一也、佐々木基、若杉英樹、北嶋洋志、新沼猛、丸山玲緒、甲斐正広、池田博、石田禎夫、佐々木泰史、時野隆至、仲瀬裕志、鈴木拓
    • Organizer
      第76回日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-15K09456
  • [Presentation] 多発性骨髄腫に有効なヒストンメチル化阻害薬の探索2016

    • Author(s)
      石黒一也,北嶋洋志,新沼 猛,丸山玲緒,甲斐正広,西山廣陽,進藤哲哉,池田 博,石田禎夫,佐々木泰史,時野隆至,仲瀬裕志,鈴木 拓
    • Organizer
      第75回日本癌学会学術総会
    • Place of Presentation
      神奈川県横浜市、パシフィコ横浜
    • Year and Date
      2016-10-06
    • Data Source
      KAKENHI-PROJECT-15K09456
  • 1.  鈴木 拓 (20381254)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 3 results
  • 2.  ISHIDA Tadao (20305220)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 5 results
  • 3.  池田 博 (60570132)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 5 results
  • 4.  丸山 玲緒 (60607985)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 4 results
  • 5.  萬 顕 (20792120)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 6.  新沼 猛 (60708113)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 1 results
  • 7.  須藤 豪太 (60830130)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 8.  山本 英一郎 (60567915)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 3 results
  • 9.  山野 泰穂
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi